
Tecan
Providing laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics.
Enterprise value
$1.8b
Share price
CHF161.80 TECN.SW
Recent deals
- Healthcare
- Chemical
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | 000k |
No items found
No investors found
CHF | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 30 % | 21 % | (6 %) | (7 %) | (5 %) | 5 % | 7 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 22 % | 19 % | 19 % | 15 % | 19 % | 20 % | 22 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 13 % | 11 % | 12 % | 10 % | 9 % | 10 % | 11 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 8 % | 7 % | 6 % | 7 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Tecan
Edit
ACQUISITION by Waters Corporation Jan 2020

ACQUISITION by Tecan Aug 2016

ACQUISITION by Tecan Jul 2014

ACQUISITION by Tecan Oct 2015